A Midwife-Led Psychoeducational Intervention to Reduce Pregnancy-Related Anxiety in Low-Risk Pregnant Women
Effectiveness of an Individual Midwife-Led Psychoeducational Intervention in Reducing Pregnancy-Related Anxiety in Pregnant Women
1 other identifier
interventional
80
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether an individualized psychoeducational intervention led by an experienced midwife can reduce pregnancy-related anxiety (PrA) in pregnant women during the second and third trimesters. The main questions it aims to answer are:
- Can individualized midwife-led psychoeducation significantly reduce pregnancy-related anxiety levels as measured by the PRAQ-R2 questionnaire?
- Does this intervention improve women's sense of control, competence, and readiness for childbirth?
- Can the intervention reduce preferences for cesarean section without medical indication among low-risk pregnant women? Participants will:
- Attend 4-6 individual sessions (approximately 60 minutes each) with a midwife, scheduled every 1-2 weeks
- Complete the Pregnancy-Related Anxiety Questionnaire (PRAQ-R2) at the beginning and end of the intervention to measure anxiety levels
- Receive evidence-based education about the physiological process of childbirth, pain management methods (both pharmacological and non-pharmacological), and medical procedures
- Learn and practice stress-reduction techniques including breathing exercises, relaxation methods, and mindfulness
- Develop an individualized birth plan and practice communication skills for effective interaction with medical personnel
- Work on cognitive strategies to address negative thoughts and build positive affirmations about childbirth
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedFirst Posted
Study publicly available on registry
January 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2028
January 7, 2026
December 1, 2025
2.2 years
December 8, 2025
December 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy-Related Anxiety Level
Measure: Change in Pregnancy-Related Anxiety Questionnaire-Revised 2 (PRAQ-R2) total score from baseline to post-intervention. Description: The PRAQ-R2 is a validated 10-item questionnaire assessing pregnancy-specific anxiety, using a 5-point Likert scale. Total scores range from 10 to 50, with higher scores indicating higher levels of pregnancy-related anxiety (worse outcome). The Polish validated version of the questionnaire will be used. A decrease in score reflects a reduction in anxiety.
Baseline (Session 1, before intervention start) and post-intervention (after completing 4-6 sessions, approximately 8-12 weeks from baseline)
Study Arms (2)
Pregnant women with high PrA levels receiving midwife-led individual psychoeducational intervention
EXPERIMENTALStandard prenatal care without additional psychoeducational intervention
NO INTERVENTIONInterventions
Individual program by midwife in 2nd/3rd trimester: 4-6 sessions (\~60min), every 1-2 weeks. Session 1: PRAQ-R2 assessment, identifying fears, building trust. Session 2: Labor stages education, myth verification, visual aids. For multiparous: previous birth discussion. Session 3: Pain management - breathing, relaxation, massage, hydrotherapy, epidural, nitrous oxide. Practical exercises. Session 4: Birth plan development, assertive communication training, role-playing. Session 5: Mindfulness, cognitive restructuring, affirmations, visualization, final PRAQ-R2. Session 6 (optional): Techniques review, birth plan finalization, Q\&A, contact plan. Materials: brochures, diagrams, videos, templates, audio instructions. Flexible, individualized.
Eligibility Criteria
You may qualify if:
- Pregnant women in the second or third trimester of pregnancy
- Elevated level of pregnancy-related anxiety (PrA)
- Low obstetric risk pregnant women (no significant medical contraindications to vaginal delivery)
- Consent to participate in individual psychoeducational sessions
- Ability to communicate in Polish at a level sufficient to understand the materials and participate in the sessions
You may not qualify if:
- Pregnant women with severe mental disorders requiring urgent psychiatric intervention
- Women with serious obstetric complications in the current pregnancy requiring intensive medical monitoring (e.g., severe hypertension, imminent preterm delivery requiring hospitalization)
- Patients already undergoing intensive psychotherapy or pharmacotherapy for anxiety
- Lack of consent to participate or inability to attend sessions (e.g., due to logistical reasons)
- Pregnant women whose pregnancy-related anxiety is not the primary concern, with other dominant anxiety disorders (e.g., GAD unrelated to pregnancy) or other priority health needs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Obstetric and Gynaecological Nursing, Faculty of Health Sciences with the Institute of Maritime and Tropical Medicine, Medical University of Gdańsk
Gdansk, 80-210, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2025
First Posted
January 7, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
February 28, 2028
Study Completion (Estimated)
February 28, 2028
Last Updated
January 7, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared to protect participant confidentiality and due to data protection regulations. Results will be published in aggregated form.